MedPage Today) -- SAN FRANCISCO -- A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...
.png)
2488 Grand Concourse, suite 314, Bronx NY 10458
+1786-550-1661
info@holdingsolutioninc.com
Copyright © 2023 holdingsolutioninc. All Rights Reserved
